Apoptosis and Expressions of Apoptosis-Related Factors in Salivary Gland Tumors |
Yoon Hye-Kyoung
(Departments of Pathology, Pusan Paik Hospital, Inje University)
Kang Mi-Seon (Departments of Pathology, Pusan Paik Hospital, Inje University) Yi Jae-Woo (Departments of Pathology, Pusan Paik Hospital, Inje University) Kim Sang-Hyo (Departments of Surgery, Pusan Paik Hospital, Inje University) |
1 | Kayaselcuk F, Nursal TZ, Polat A, et al: Expression of survivin, bcl-2, p53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a). J Exp Clin Cancer Res. 2004;23:105-112 |
2 | Karja VJ, Syrjanen KJ, Kurvinen A-K, Syrjanen SM: Expression and mutations of p53 in salivary gland tumors. J Oral Pathol Med. 1997;26:217-223 DOI ScienceOn |
3 | Kapuccuglu N, Losi L, Eusebi V: Immunohistochemical localization of Bcl-2 and Bax proteins in in situ and invasive duct breast carcinomas. Virchows Arch. 1997;430:17-22 DOI ScienceOn |
4 | Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710-1715 |
5 | Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80:293-299 DOI ScienceOn |
6 | Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124:1-6 DOI |
7 | Nagao T, Sugano I, Ishida Y, et al. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2. Cancer. 1998;82:439-447 DOI ScienceOn |
8 | Soini Y, Tormanen U, Paakko P: Apoptosis is inversely related to bcl-2 but not to bax expression in salivary gland tumours. Histopathology. 1998;32:28-34 DOI ScienceOn |
9 | Yin HF, Okada N, Takagi M: Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands. Pathol Int. 2000;50:603-609 DOI ScienceOn |
10 | Kerr JF, Winterford CM, Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer. 1994;73;2013-2036 DOI ScienceOn |
11 | Garrity MM, Burgart LJ, Mahoney MR, et al: Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. J Clin Oncol. 2004;22:1572-1582 DOI ScienceOn |
12 | Hockenbery DM: bcl-2 in cancer, development and apoptosis. J Cell Sci. 1994;18:51-55 |
13 | Yang J, Liu X, Bhalla K, et al: Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275:1129-1132 DOI ScienceOn |
14 | Baretton GB, Diebold J, Christoforis G, et al: Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer. 1996;77:255-264 DOI ScienceOn |
15 | Jia L, Esguerra RL, Tang X, et al: Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma. Pathol Int. 2004;54:217-223 DOI ScienceOn |
16 | Kroemer G: The proto-oncogene bcl-2 and its role in regulation of apoptosis. Nature Med. 1997;3:614-620 DOI ScienceOn |
17 | Xin W, Paulino AF: Prognostic factors in malignant mixed tumors of the salivary gland: correlation of immunohistochemical markers with histologic classification. Ann Diagn Pathol. 2002; 6:205-210 DOI ScienceOn |
18 | Yanez M, Roa I, Garcia M, Ibacache G, Villaseca M: Bcl-2 gene protein expression in salivary gland tumors. Rev Med Chil. 1999; 127:139-142 |
19 | Pammer J, Horvat R, Weninger W, Ulrich W: Expression of bel-2 in salivary glands and salivary gland adenomas. A contribution to the reserve cell theory. Res Pract. 1995;191:35-41 DOI |
20 | Kusama K, Jiang Y, Toguchi M, et al: Use of the monoclonal antibody M30 for detecting HSG cell apoptosis. Anticancer Res. 2000;20:151-154 |